Treatment Options
Compare MyStart's featured treatment paths
These pages are built around the two medication decisions MyStart buyers usually make: semaglutide and tirzepatide. Each page keeps the offer tied to clinician review, support expectations, and trust documentation.
Adults looking for a practical semaglutide starting point with simpler weekly treatment expectations and a clearer self-pay process.
Review MyStart Health's semaglutide pathway, including the qualification flow, clinician review, shipping expectations, and ongoing support structure.
- Built for people who want a familiar weekly GLP-1 path before exploring more aggressive options
- Pairs qualification and clinician review with discreet shipping and ongoing support if prescribed
- Keeps the semaglutide decision tied to price transparency, support access, and disclosure pages
Adults comparing the stronger tirzepatide-led path and wanting tighter clarity around approval, pricing, and support before they begin.
Explore MyStart Health's tirzepatide pathway, including clinician review, self-pay expectations, shipping timing, and support after approval.
- Designed for visitors who already know they want to evaluate tirzepatide specifically
- Keeps the medication decision connected to clinician review, cash-pay planning, and ongoing support
- Explains the path without implying guaranteed approval, guaranteed outcomes, or one-size-fits-all fit